292 related articles for article (PubMed ID: 4097002)
1. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
2. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
3. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
4. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
Aliakparova ASh
Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
[No Abstract] [Full Text] [Related]
5. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
6. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA; Kloppenborg PW
J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
[No Abstract] [Full Text] [Related]
7. Thyroid physiology and functional tests.
Zellmann HE
Major Probl Clin Surg; 1980; 15():70-84. PubMed ID: 6893732
[No Abstract] [Full Text] [Related]
8. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Chopra IJ; Chopra U; Orgiazzi J
J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
[No Abstract] [Full Text] [Related]
9. Investigation of endocrine exophthalmos.
Bowden AN; Ross FC
Proc R Soc Med; 1969 Jan; 62(1):13-5. PubMed ID: 5818230
[No Abstract] [Full Text] [Related]
10. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
11. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
12. Thyroid physiology and functional tests.
Zellmann HE
Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
[No Abstract] [Full Text] [Related]
13. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
14. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.
Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
J Clin Endocrinol Metab; 1967 Dec; 27(12):1682-9. PubMed ID: 4168655
[No Abstract] [Full Text] [Related]
15. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
16. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
17. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
Földes J; Gesztesi E; Takács I
Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
[No Abstract] [Full Text] [Related]
18. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
19. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
Stewart RD
N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311
[No Abstract] [Full Text] [Related]
20. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
